Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.
Cornell experts have launched the Aging and Climate Change Clearinghouse to promote research, policies and activism addressing the need to protect vulnerable older adults in the face of climate challenges.
For her work in developing and teaching nutrition and food justice curricula to adolescents in New York City, Hannah Rudt ’23 has won the 2023 National Student Employee of the Year award – the first Cornellian to ever receive this honor.
A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.
Due to faster decomposition, disposable and plasticized biodegradable medical gowns introduce greenhouse gas discharge problems in landfills, according to new Cornell engineering research.
Students and lifelong learners are invited to explore a new interest, enhance their resume or strengthen their professional skills through Cornell’s Fall Part-Time Study Program, which runs Aug. 22 – Dec. 17, 2022. Registration for most students begins August 1.
An interdisciplinary Cornell team has identified a new mechanism regulating tumor growth in the skeleton, the primary site of breast cancer metastasis: mineralization of the bone matrix.
In a first-of-its-kind analysis, Cornell researchers and partners at the Clinton Health Access Initiative found that pharmaceutical producers could reduce their environmental impact by roughly half by optimizing manufacturing processes and supply chain networks and by switching to renewable energy sources.
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
Dr. Myles Wolf will lead the institutions’ largest clinical and academic department, overseeing 16 divisions and nearly 2,250 physicians and scientists.